CYP1B1 was found to be significantly overexpressed in bone sarcomas (osteosarcoma, 78%; chondrosarcoma, 82.1%), whereas healthy normal bone tissues displayed minimal expression (12.5%, p < 0.001). Here, CYP1B1 is linked to osteosarcoma.